| pubmed-article:17140760 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17140760 | lifeskim:mentions | umls-concept:C0021760 | lld:lifeskim |
| pubmed-article:17140760 | lifeskim:mentions | umls-concept:C0085295 | lld:lifeskim |
| pubmed-article:17140760 | lifeskim:mentions | umls-concept:C2239176 | lld:lifeskim |
| pubmed-article:17140760 | lifeskim:mentions | umls-concept:C0041365 | lld:lifeskim |
| pubmed-article:17140760 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:17140760 | lifeskim:mentions | umls-concept:C1447107 | lld:lifeskim |
| pubmed-article:17140760 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17140760 | pubmed:dateCreated | 2007-3-9 | lld:pubmed |
| pubmed-article:17140760 | pubmed:abstractText | Serum alpha-fetoprotein (AFP) is the most important tumor marker for hepatocellular carcinoma (HCC). Previous reports indicated that HCC was also associated with increased levels of interleukin (IL)-6, IL-10 and hepatocyte growth factor (HGF). This study investigated the role of these cytokines as tumor markers for HCC. | lld:pubmed |
| pubmed-article:17140760 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17140760 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140760 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17140760 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140760 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140760 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140760 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17140760 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17140760 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:17140760 | pubmed:issn | 0748-7983 | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:LOJJ | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:ErbKK | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:KokkKh IKhI | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:LueT FTF | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:YeoE LEL | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:BuiK QKQ | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:DíazJ DJD | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:SunC-LCL | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:ChiangS-YSY | lld:pubmed |
| pubmed-article:17140760 | pubmed:author | pubmed-author:LuM-FMF | lld:pubmed |
| pubmed-article:17140760 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17140760 | pubmed:volume | 33 | lld:pubmed |
| pubmed-article:17140760 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17140760 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17140760 | pubmed:pagination | 208-12 | lld:pubmed |
| pubmed-article:17140760 | pubmed:dateRevised | 2007-7-2 | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:meshHeading | pubmed-meshheading:17140760... | lld:pubmed |
| pubmed-article:17140760 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17140760 | pubmed:articleTitle | Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma. | lld:pubmed |
| pubmed-article:17140760 | pubmed:affiliation | Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan. | lld:pubmed |
| pubmed-article:17140760 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17140760 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
